The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Watkins Tim since 2025.
This trader's CIK number is 2065965.
At the time of last reporting, Watkins Tim was the CMO & Head of Development of Contineum Therapeutics, Inc.. (stock ticker symbol CTNM).
Also see all insider trading activities at Contineum Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CTNM | 0 | $0 | 3,611 | $43,559 | 3,611 | $16,249 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-29 | CTNM | Sale | 3,611 | 12.06 | 43,559 |
| 2025-12-29 | CTNM | Option Ex | 3,611 | 4.50 | 16,249 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Watkins Tim (CMO & Head of Development of Contineum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.